Jubilant Life Sciences has signed a long-term supply agreement in proprietary products business with a leading international life sciences company. The total contract is valued at over $80 million to be executed in three years beginning the April–June 2012 quarter.
According to the company, the product has a huge demand in the market and has already received advance payment from its customer on the signing of the deal. The product would be made using its in-house technology and raw material to make it cost-effective. This contract has a minimum volume ‘take or pay’ commitment and has an opportunity to go over $100 million. crackcrack
